China Nuokang Bio-Pharmaceutical, Inc. (NKBP) Tops Q2 EPS by 3c
Tweet
Share
E-mailGet Alerts NKBP Hot Sheet
Join SI Premium – FREE
China Nuokang Bio-Pharmaceutical, Inc. (NASDAQ: NKBP) reported Q2 EPS of $0.11, $0.03 better than the analyst estimate of $0.08. Revenue for the quarter came in at $12.3 million versus the consensus estimate of $10 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Medtronic (MDT) Tops Q1 EPS by 6c, Beats on Revenue; Offers FY27 EPS Guidance
- Dollar Tree (DLTR) Tops Q2 EPS by $1.59, Beats on Revenue; Offers FY Guidance
- Marvell Technology (MRVL) Tops Q2 EPS by 1c, Offers Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
